Pfizer Colorectal Cancer Trial Win Adds Weight To Oncology Turnaround Story
Pfizer (NYSE:PFE) reported positive topline results from its pivotal BREAKWATER trial. The study evaluated a BRAFTOVI based combination in previously ...
Strong Bullish
100.0